International Expert Opinion on Optimal Switching to Cladribine Tablets from Other High-Efficacy Disease-Modifying Therapies for Relapsing–Remitting Multiple Sclerosis: Opportunities and Challenges.
Saved in:
| Title: | International Expert Opinion on Optimal Switching to Cladribine Tablets from Other High-Efficacy Disease-Modifying Therapies for Relapsing–Remitting Multiple Sclerosis: Opportunities and Challenges. |
|---|---|
| Authors: | Chan, Andrew1 (AUTHOR), Alroughani, Raed2 (AUTHOR), Calabrese, Massimiliano3 (AUTHOR), Havrdová, Eva Kubala4 (AUTHOR), Obeidat, Ahmed Z.5 (AUTHOR), Schmierer, Klaus6,7 (AUTHOR), Andersson, Magnus8 (AUTHOR), Bek, Louise9 (AUTHOR), Savarin, Carine10 (AUTHOR), Korich, Julie11 (AUTHOR), Bonsignore, Luca12 (AUTHOR), de Seze, Jérôme13 (AUTHOR) jerome.deseze@chru-strasbourg.fr |
| Source: | Neurology & Therapy. Jun2026, Vol. 15 Issue 3, p887-906. 20p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
